US 9987233
Injectable sustained release composition and method of using the same for treating inflammation in joints and pain associated therewith
granted A61KA61K31/56A61K31/58
Quick answer
US patent 9987233 (Injectable sustained release composition and method of using the same for treating inflammation in joints and pain associated therewith) held by Eupraxia Pharmaceuticals USA LLC expires Mon May 31 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Eupraxia Pharmaceuticals USA LLC
- Grant date
- Tue Jun 05 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 31 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61K, A61K31/56, A61K31/58, A61K9/0024, A61K9/5026